Curanex Pharmaceuticals formalizes CEO/COO agreements; base salaries $393,600 and $180,000

Curanex Pharmaceuticals Inc

CEO Jun Liu: annual base salary $393,600, three-year term, plus $3,998/month auto lease.
COO Dr. Liqin Xie: annual salary $180,000, at-will employment, three-month severance on without-cause termination.
CEO served without compensation from Feb 2024 to Aug 2025; received $325,000.08 for past services through March 1, 2026.
Both agreements include 18-month non-compete (CEO), non-solicitation, and clawback provisions under policy effective Aug 12, 2025.
Termination without cause or for good reason triggers 3 months' salary continuation and immediate equity vesting for both.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.